AZACITIDINE
- Product NDC
- 72606-558
- 11-digit product format
- 726060558
- Labeler code
- 72606
- Product ID
- 72606-558_1542236d-9049-4a6b-8956-c53d38f8520c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- azacitidine
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS; SUBCUTANEOUS
- Labeler
- CELLTRION USA, INC.
- Application
- ANDA207518
- Marketing category
- ANDA
- Marketing start
- 2020-01-06
- Marketing end
- 0000-00-00
- Substance
- AZACITIDINE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72606-558-01 | 72606055801 | 1 VIAL in 1 CARTON (72606-558-01) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL | 1 vial | 2020-01-06 | 0000-00-00 | No | No | Current |